BIO WEBINAR LG Chem speeding up new drug development
Yoon Soo-hee, senior vice president and head of the Specialty Care Division at LG Chem, speaks during The Korea Times' Bio Webinar, March 26. Captured during the eventBy Baek Byung-yeulLogo for LG ChemLG Chem, the chemical, battery-making and biotech affiliate of LG Group, is improving research and development in new drug development to find new growth engines.During The Korea Times' Bio Webinar, on March 26, Yoon Soo-hee, senior vice president and head of the Specialty Care Division at LG Chem, said the company focused on developing drugs for diabetes, metabolic disorders, cancer and immune disorders as its main R&D areas in 2017.As part of that plan, LG Chem has been conducting over 40 new drug development pipelines, investing 600 billion won ($532 million) over the past four years.The webinar was sponsored by the Ministry of Trade, Industry and Energy. The executives of the country's prominent biotech firms ― LG Chem, Samsung Biologics, SK Bioscience and Celltrion ― discussed the current state of the local biotech industry and what types of support the government needs to offe
Mar 28, 2021By Baek Byung-yeul